These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31570490)

  • 1. Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma.
    Chiu BC; Zhang Z; You Q; Zeng C; Stepniak E; Bracci PM; Yu K; Venkataraman G; Smith SM; He C; Zhang W
    Blood Adv; 2019 Oct; 3(19):2790-2799. PubMed ID: 31570490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Hydroxymethylcytosine profiles of cfDNA are highly predictive of R-CHOP treatment response in diffuse large B cell lymphoma patients.
    Chen HY; Zhang WL; Zhang L; Yang P; Li F; Yang ZR; Wang J; Pang M; Hong Y; Yan C; Li W; Liu J; Xu N; Chen L; Xiao XB; Qin Y; He XH; Liu H; Zhu HC; He C; Lin J; Jing HM
    Clin Epigenetics; 2021 Feb; 13(1):33. PubMed ID: 33573703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of 5-hydroxymethylcytosines in circulating cell-free DNA reflect retinopathy in type 2 diabetes.
    Han L; Chen C; Lu X; Song Y; Zhang Z; Zeng C; Chiu R; Li L; Xu M; He C; Zhang W; Duan S
    Genomics; 2021 Jan; 113(1 Pt 1):79-87. PubMed ID: 33221518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-Free DNA 5-Hydroxymethylcytosine Signatures for Lung Cancer Prognosis.
    Shao J; Olsen RJ; Kasparian S; He C; Bernicker EH; Li Z
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia.
    Shao J; Wang S; West-Szymanski D; Karpus J; Shah S; Ganguly S; Smith J; Zu Y; He C; Li Z
    Sci Rep; 2022 Jul; 12(1):12410. PubMed ID: 35859008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma.
    Xiao Z; Wu W; Wu C; Li M; Sun F; Zheng L; Liu G; Li X; Yun Z; Tang J; Yu Y; Luo S; Sun W; Feng X; Cheng Q; Tao X; Wu S; Tao J
    Mol Oncol; 2021 Jan; 15(1):138-150. PubMed ID: 33107199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.
    Chen L; Shen Q; Xu S; Yu H; Pei S; Zhang Y; He X; Wang Q; Li D
    J Alzheimers Dis; 2022; 85(2):573-585. PubMed ID: 34864677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma.
    Cai J; Chen L; Zhang Z; Zhang X; Lu X; Liu W; Shi G; Ge Y; Gao P; Yang Y; Ke A; Xiao L; Dong R; Zhu Y; Yang X; Wang J; Zhu T; Yang D; Huang X; Sui C; Qiu S; Shen F; Sun H; Zhou W; Zhou J; Nie J; Zeng C; Stroup EK; Zhang X; Chiu BC; Lau WY; He C; Wang H; Zhang W; Fan J
    Gut; 2019 Dec; 68(12):2195-2205. PubMed ID: 31358576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomas.
    Hur JY; Kim YJ; Yoon SE; Son DS; Park WY; Kim SJ; Park D; Kim WS
    Ann Hematol; 2020 Jun; 99(6):1293-1302. PubMed ID: 32296914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cell-free DNA concentration as a possible prognostic marker in newly diagnosed diffuse large B-cell lymphoma.
    Shirouchi Y; Mishima Y; Takayama T; Minowa S; Ishihara Y; Tamba M; Hirano M; Onda N; Takeuchi K; Maruyama D
    Biomed Res; 2022; 43(4):99-106. PubMed ID: 35989290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of 5-hydroxymethylcytosine as a Poor Prognostic Factor for Primary Testicular Diffuse Large B-cell Lymphoma.
    Shen Y; Wang L; Ou J; Wang B; Cen X
    Int J Med Sci; 2022; 19(2):225-232. PubMed ID: 35165508
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-Hydroxymethylcytosines in circulating cell-free DNA as a diagnostic biomarker for nasopharyngeal carcinoma.
    Chen B; Wang D; Xu Y; Guo Q; Pan J; Yu S; Fang Y; Xiao S; Ruan Y; Yang S; Lin M; Hong J; Zhan Z; Lin S
    Eur J Cancer; 2024 Oct; 210():114294. PubMed ID: 39213787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Hydroxymethylation alterations in cell-free DNA reflect molecular distinctions of diffuse large B cell lymphoma at different primary sites.
    Shen Y; Ou J; He B; Yang J; Liu H; Wang L; Wang B; Gao L; Yi C; Peng J; Cen X
    Clin Epigenetics; 2022 Oct; 14(1):126. PubMed ID: 36221115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study.
    Chang W; Zhang Z; Jia B; Ding K; Pan Z; Su G; Zhang W; Liu T; Zhong Y; He G; Ren L; Wei Y; Li D; Cui X; Yang J; Shi Y; Bissonnette M; He C; Zhang W; Fan J; Xu J
    Clin Cancer Res; 2024 Aug; 30(15):3337-3348. PubMed ID: 38814264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxymethylcytosine profiling from genomic and cell-free DNA for colorectal cancers patients.
    Gao P; Lin S; Cai M; Zhu Y; Song Y; Sui Y; Lin J; Liu J; Lu X; Zhong Y; Cui Y; Zhou P
    J Cell Mol Med; 2019 May; 23(5):3530-3537. PubMed ID: 30912288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers.
    Li W; Zhang X; Lu X; You L; Song Y; Luo Z; Zhang J; Nie J; Zheng W; Xu D; Wang Y; Dong Y; Yu S; Hong J; Shi J; Hao H; Luo F; Hua L; Wang P; Qian X; Yuan F; Wei L; Cui M; Zhang T; Liao Q; Dai M; Liu Z; Chen G; Meckel K; Adhikari S; Jia G; Bissonnette MB; Zhang X; Zhao Y; Zhang W; He C; Liu J
    Cell Res; 2017 Oct; 27(10):1243-1257. PubMed ID: 28925386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Hydroxymethylcytosine in Cell-Free DNA Predicts Immunotherapy Response in Lung Cancer.
    Shao J; Xu Y; Olsen RJ; Kasparian S; Sun K; Mathur S; Zhang J; He C; Chen SH; Bernicker EH; Li Z
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Hydroxymethylcytosine signals in serum are a predictor of chemoresistance in high-grade serous ovarian cancer.
    Weigert M; Cui XL; West-Szymanski D; Yu X; Bilecz AJ; Zhang Z; Dhir R; Kehoe M; Zhang W; He C; Lengyel E
    Gynecol Oncol; 2024 Mar; 182():82-90. PubMed ID: 38262243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease.
    Beadell AV; Zhang Z; Capuano AW; Bennett DA; He C; Zhang W; Arvanitakis Z
    J Alzheimers Dis; 2023; 93(3):1135-1151. PubMed ID: 37182870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Hydroxymethylcytosines in Circulating Cell-Free DNA Reveal Vascular Complications of Type 2 Diabetes.
    Yang Y; Zeng C; Lu X; Song Y; Nie J; Ran R; Zhang Z; He C; Zhang W; Liu SM
    Clin Chem; 2019 Nov; 65(11):1414-1425. PubMed ID: 31575611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.